Intellia Therapeutics Inc buy Barclays PLC
Start price
07.11.25
/
50%
€8.12
Target price
07.11.26
€12.13
Performance (%)
38.79%
Price
11.03.26
€11.27
Summary
This prediction is currently active. With a performance of 38.79% the BUY prediction by Barclays_PLC is a big success. This prediction currently runs until 07.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -0.683% | -0.683% |
| iShares Core DAX® | -3.520% | -4.987% |
| iShares Nasdaq 100 | 0.261% | 1.102% |
| iShares Nikkei 225® | -4.953% | -3.352% |
| iShares S&P 500 | -0.823% | -0.042% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) had its price target lowered by analysts at Barclays PLC from $24.00 to $14.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Barclays_PLC for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.82
28.02.25
28.02.25
€25.05
28.02.26
28.02.26
11.87%
01.03.26
01.03.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.58
08.11.24
08.11.24
€51.38
08.11.25
08.11.25
-41.87%
09.11.25
09.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€36.00
04.08.23
04.08.23
€81.52
04.08.24
04.08.24
-40.22%
05.08.24
05.08.24